BioCentury
ARTICLE | Clinical News

BioSpecifics, Tufts University regulatory update

June 14, 1999 7:00 AM UTC

The parties jointly received U.S. Patent No. 5,851,522 covering an enzyme formulation consisting of the collagenase enzyme and the hbEGF growth factor as a wound healing agent. ...